We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
(+7.3%)
Cap. Flow
-$5.71M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3.6
quarters
Top 10 Avg Time Held Equity + Options
2.1
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.9
quarters
Top 10 Avg Time Held Equity only
3.5
quarters
Top 20 Avg Time Held Equity only
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$1.13M |
| 2 |
Biogen
BIIB
|
+$803K |
| 3 |
AbbVie
ABBV
|
+$773K |
| 4 |
MGM Resorts International
MGM
|
+$610K |
| 5 |
Kearny Financial
KRNY
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.79M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.34M |
| 3 |
General Motors Company
GM.WS.B
|
+$1.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$857K |
| 5 |
Taro Pharmaceutical Industries Ltd.
TARO
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.05% |
| 2 | Miscellaneous | 33% |
| 3 | Healthcare | 14.28% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Technology | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Towne Bank
TOWN
$3.26B
| $407K | 0.25% |
25,000
| – | – |
2015 Q1
1 quarter
|
|
77
DexCom
DXCM
$32.3B
| $400K | 0.25% |
20,000
-20,000
| -50% | -$351K |
2013 Q2
8 quarters
|
|
78
Waterstone Financial
WSBF
$356M
| $396K | 0.25% |
30,000
| – | – |
2014 Q1
5 quarters
|
|
|
FNM.PRS
79
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
| $394K | 0.25% |
105,000
| – | – |
2013 Q3
7 quarters
|
|
80
Arrowhead Research
ARWR
$8.56B
| $393K | 0.24% |
55,000
-10,000
| -15% | -$68.7K |
2014 Q4
2 quarters
|
|
81
RH
RH
$2.23B
| $391K | 0.24% |
4,000
| – | – |
2013 Q2
8 quarters
|
|
82
Burlington
BURL
$16.9B
| $384K | 0.24% |
7,500
-2,500
| -25% | -$134K |
2013 Q4
6 quarters
|
|
|
BVA
83
DELISTED
CORDIA BANCORP INC COM
BVA
| $383K | 0.24% |
100,100
-600
| -0.6% | -$2.31K |
2014 Q3
3 quarters
|
|
84
DELISTED
Hologic
HOLX
| $381K | 0.24% |
10,000
-5,000
| -33% | -$175K |
2014 Q2
4 quarters
|
|
|
HLND
85
DELISTED
HILAND PARTNERS, LP COMMON UNITS
HLND
| $374K | 0.23% |
93,510
| – | – |
2014 Q2
4 quarters
|
|
|
LGF
86
CALL
DELISTED
Lions Gate Entertainment
LGF
| $371K | 0.23% |
10,000
| – | – |
2015 Q1
1 quarter
|
|
|
RKUS
87
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $367K | 0.23% |
35,500
-27,000
| -43% | -$309K |
2015 Q1
1 quarter
|
|
88
DELISTED
Qorvo
QRVO
| $361K | 0.22% |
+4,500
| New | +$349K |
2015 Q2
0 quarters
|
|
89
ALPS Medical Breakthroughs ETF
SBIO
$188M
| $355K | 0.22% |
+10,000
| New | +$327K |
2015 Q2
0 quarters
|
|
90
DELISTED
Amicus Therapeutics
FOLD
| $354K | 0.22% |
25,000
+5,000
| +25% | +$60.1K |
2015 Q1
1 quarter
|
|
91
DELISTED
PotlatchDeltic
PCH
| $353K | 0.22% |
10,000
| – | – |
2013 Q2
8 quarters
|
|
92
DELISTED
Hess
HES
| $348K | 0.22% |
5,200
-5,000
| -49% | -$355K |
2013 Q2
8 quarters
|
|
|
CSOD
93
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $348K | 0.22% |
+10,000
| New | +$311K |
2015 Q2
0 quarters
|
|
|
MNTA
94
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $342K | 0.21% |
+15,000
| New | +$299K |
2015 Q2
0 quarters
|
|
|
ADEP
95
DELISTED
Adept Technology Inc
ADEP
| $342K | 0.21% |
47,500
-17,500
| -27% | -$109K |
2014 Q1
5 quarters
|
|
96
Alaunos Therapeutics
TCRT
$2.43M
| $341K | 0.21% |
189
-312
| -62% | -$484K |
2013 Q3
7 quarters
|
|
|
GNC
97
DELISTED
GNC Holdings, Inc.
GNC
| $334K | 0.21% |
+7,500
| New | +$342K |
2015 Q2
0 quarters
|
|
98
DELISTED
Du Pont De Nemours E I
DD
| $333K | 0.21% |
5,476
| – | – |
2014 Q1
5 quarters
|
|
|
PFPT
99
DELISTED
Proofpoint, Inc.
PFPT
| $318K | 0.2% |
+5,000
| New | +$294K |
2015 Q2
0 quarters
|
|
100
DELISTED
Jive Software, Inc.
JIVE
| $315K | 0.2% |
60,000
-10,000
| -14% | -$55.5K |
2014 Q4
2 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2015 Portfolio in Review
As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.
- E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
- E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
- E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
- E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
- E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
- E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
- E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.